North America Human Insulin Market Growth, 2020-2026: By Product Type, Application, Distribution Channel & Country - ResearchAndMarkets.com

The "North America Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

North America human insulin market is expected to reach $23.52 billion by 2025, growing by 7.36% annually over the next years.

Highlighted with 27 tables and 52 figures, this 105-page report North America Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify North America human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Country.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.1.1 Industry Definition

1.1.2 Research Scope

1.2 Research Methodology

1.2.1 Overview of Market Research Methodology

1.2.2 Market Assumption

1.2.3 Secondary Data

1.2.4 Primary Data

1.2.5 Data Filtration and Model Design

1.2.6 Market Size/Share Estimation

1.2.7 Research Limitations

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter's Fiver Forces Analysis

3 Segmentation of North America Market by Product Type

3.1 Market Overview by Product Type

3.2 Human Insulin Drugs

3.3 Human Insulin Delivery Devices

4 Segmentation of North America Human Insulin Drugs Market by Drug Product

4.1 Market Overview by Drug Product

4.2 Modern Human Insulin

4.2.1 Modern Human Insulin by Type

4.2.2 Modern Human Insulin by Brand

4.3 Traditional Human Insulin

4.3.1 Traditional Human Insulin by Type

4.3.2 Traditional Human Insulin by Brand

5 Segmentation of North America Human Insulin Delivery Devices Market by Device Product

5.1 Market Overview by Product

5.2 Syringes

5.3 Pens

5.4 Pumps

5.5 Other Devices

6 Segmentation of North America Market by Application

6.1 Market Overview by Application

6.2 Type 1 Diabetes

6.3 Type 2 Diabetes

6.4 Gestational Diabetes and Prediabetes

7 Segmentation of North America Market by Distribution Channel

7.1 Market Overview by Distribution Channel

7.2 Hospital Pharmacies

7.3 Retail Pharmacies

7.4 Online Pharmacies

8 North America Market 2019-2026 by Country

8.1 Overview of North America Market

8.2 U.S. Market

8.3 Canadian Market

9 Competitive Landscape

9.1 Overview of Key Vendors

9.2 New Product Launch, Partnership, Investment, and M&A

9.3 Company Profiles

• Astra Zeneca PLC
• Biocon
• Eli Lilly
• Exir
• Julphar
• Novo Nordisk AS
• Pfizer
• Sanofi Aventis
• Sedico
• Wockhardt

10 Investing in North America Market: Risk Assessment and Management

10.1 Risk Evaluation of North America Market

10.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/b933dd

View source version on businesswire.com: https://www.businesswire.com/news/home/20200123005363/en/